Revium Rx (RVRC) Cash & Equivalents (2024 - 2026)
Revium Rx (RVRC) posted Cash & Equivalents of $1.7 million for Q4 2025, down 48.65% sequentially from $3.3 million in Q4 2024, and down 48.65% YoY from $3.3 million in Q4 2024.
Revium Rx (RVRC) Cash & Equivalents (2024 - 2026) Analysis & Trends
Revium Rx has reported Cash & Equivalents for 2 years, with the latest figure at $1.7 million in Q4 2025.
- Quarterly Cash & Equivalents fell 48.65% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 48.65% YoY) and the FY2025 annual result came in at $1.7 million, down 48.65% from the prior year.
- Cash & Equivalents slipped to $1.7 million in Q4 2025 per RVRC's latest filing, from $3.3 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $3.3 million in Q4 2024 and troughed at $1.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 1.90 Bn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 550.38 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 265.37 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 502.51 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 286.22 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 298.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 12.65 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 273.60 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | 246.80 Mn |
| 10 | Revium Rx | 101.42 Mn | 99.91 Mn | - | 842,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 842,000.00 |
| Dec 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 3.27 Mn |